A potential new vaccine for COVID-19.  The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Corona Virus. First Omicron death in Australia

‘This is the first known case of Omicron’s death in NSW,’ the…

Data on an unusual event has been declassified: in 2014, an object from outside the solar system burned up in the Earth’s atmosphere!

The US Space Command admitted that an extrasolar object appeared in the…

European forests are seriously threatened. Climate change

There are few tree species that will be able to survive such…

Why 3000 years ago shrunk the human brain? Scientists’ new hypothesis

Studying the evolution of the human brain based on the remains of…